Delivery Order SPE2DR25D2101-SPE2DR26F47NL
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,615.80 for Ferumoxytol 510 mg/17 ml vials on January 20, 2026, with completion scheduled for January 21, 2026. This is a firm fixed-price, non-set-aside award issued under a competitive procurement process. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a $9,829.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract is a non-set-aside award with an ultimate completion date of January 9, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,532.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract, which is not set aside for any specific business category, represents a competitively awarded transaction with an ultimate completion date of January 21, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $11,624.29 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $13,988.34 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award through open procurement. Performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025. This delivery order represents a relatively...
- The Defense Logistics Agency awarded a $1,351.00 delivery order to AmerisourceBergen Drug Corp for Ferumoxytol 510 mg/17 mL vials on November 5, 2025, with completion expected by November 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials with a firm fixed price ceiling value of $4,988.61. This is a non-set-aside competitively awarded delivery order with an ultimate completion date of November 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,091.56 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This contract, awarded on November 18, 2025, utilizes a firm fixed price structure with an ultimate completion date of November 19, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under a non-set-aside, competitively awarded vehicle and represents a...
- The Defense Logistics Agency awarded a $9,667.42 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract utilizes firm fixed price pricing with a completion date of September 16, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs this delivery order from its corporate office location in the same...
- The Defense Logistics Agency awarded a $5,213.69 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials on October 16, 2025, with an ultimate completion date of October 17, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F47NLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,720.55 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This competitively awarded, firm fixed-price contract carries an ultimate completion date of January 21, 2026, with performance to be fulfilled from the awardee's location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. This master contract vehicle enables the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and critical medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical vendor for federal medical procurement needs serving military and veteran healthcare systems. The company's established federal contracting history demonstrates its capability to meet diverse pharmaceutical supply requirements through open competition, with this particular delivery order supporting DLA's medical supply chain operations. No set-aside designation was applied to this award, reflecting the company's competitive standing in the open marketplace for federal pharmaceutical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 1/19/26 |